ABCAM INC

ABCAM INC specializes in the manufacturing of non-diagnostic biological products, with a focused expertise in the development and production of monoclonal antibody reagent kits and related biologics for research and therapeutic applications. The company demonstrates deep technical proficiency in cell line development, protein purification, and GMP-aligned manufacturing processes essential for producing high-purity, consistent biological reagents. Their work supports critical biomedical research initiatives, particularly in immunology and preclinical model systems, with a demonstrated ability to deliver complex, mission-critical biological materials under stringent quality controls. Key differentiators include precision in murine monoclonal antibody production and the capacity to manage rapid-scale reagent deployment for time-sensitive federal research programs. ABCAM INC maintains a consistent and longstanding relationship with the Department of Health and Human Services, delivering specialized biological reagents to support research arms such as the National Institutes of Health, particularly the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Their engagements center on supplying validated antibody-based tools for in vivo and in vitro studies, indicating a trusted role in enabling NIH-funded scientific discovery through reliable, high-quality biological materials. The company’s primary industry focus is Biological Product (Except Diagnostic) Manufacturing (NAICS 325414), positioning them as a niche supplier of research-grade biologics rather than clinical therapeutics. They serve the biomedical research ecosystem by producing monoclonal antibodies and related reagents used in animal models, assay development, and immunological studies, filling a critical gap between academic research and commercial-scale biomanufacturing. ABCAM INC is a small business structured as a 2L entity, headquartered in Waltham, Massachusetts, with no active government certifications. Their geographic proximity to major biomedical research hubs enhances their ability to collaborate with federal science agencies, reinforcing their role as a specialized, mission-aligned contractor in the life sciences supply chain.